GMO's emerging market high-flyers

Bill Nemerever and Tom Cooper, co-managers of GMO's emerging markets debt portfolio, have made their names sourcing cheap debt in unusual locations. Shunning roadshows and local currencies, they barely even travel to the countries they invest in. Dalia Fahmy meets the EM fund managers who are beating the benchmark from their armchairs

pg24-bill-jpg

Forget everything you know about investing in emerging markets, because at Boston-based investment firm GMO things work a little differently. Bill Nemerever and Tom Cooper, co-founders and co-managers of GMO's $5 billion emerging markets debt portfolio, don't travel to the countries they invest in. They avoid roadshows. They don't trust local currency bonds, even though most fund managers today think local debt is a hot opportunity.

"Roadshows are not very productive," says Cooper, 50. An avid

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here